Literature DB >> 31777664

Red Cell Volume Distribution Width as Another Biomarker.

Artemio García-Escobar1, Juan Manuel Grande Ingelmo2.   

Abstract

Year:  2019        PMID： 31777664      PMCID： PMC6848947          DOI： 10.15420/cfr.2019.13.1

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN： 2057-7540


× No keyword cloud information.
  27 in total

1.  Complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER trial.

Authors:  Benjamin D Horne; Jeffrey L Anderson; Joseph B Muhlestein; Paul M Ridker; Nina P Paynter
Journal:  Eur J Prev Cardiol       Date:  2014-01-08       Impact factor: 7.804

2.  Red cell distribution width and additive risk prediction for major bleeding in non-ST-segment elevation acute coronary syndrome.

Authors:  Marianela Sánchez-Martínez; Angel López-Cuenca; Francisco Marín; Pedro J Flores-Blanco; Andrea García Narbon; Ignacio de las Heras-Gómez; María J Sánchez-Galian; Mariano Valdés-Chávarri; James L Januzzi; Sergio Manzano-Fernández
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2014-05-16

3.  Hematological predictors and clinical outcomes in cardiac surgery.

Authors:  Bahar Aydınlı; Aslı Demir; Çiğdem Yıldırım Güçlü; Demet Bölükbaşı; E Utku Ünal; Rabia Koçulu; Gökçe Selçuk
Journal:  J Anesth       Date:  2016-06-09       Impact factor: 2.078

4.  Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure.

Authors:  Kirkwood F Adams; Mandeep R Mehra; Ron M Oren; Christopher M O'Connor; Jun R Chiong; Jalal K Ghali; Daniel J Lenihan; Stephanie H Dunlap; J Herbert Patterson; Todd A Schwartz; G Michael Felker
Journal:  Am Heart J       Date:  2010-12       Impact factor: 4.749

5.  Persistent increase in red cell size distribution width after acute diseases: A biomarker of hypoxemia?

Authors:  Joseph W Yčas; Jay C Horrow; Benjamin D Horne
Journal:  Clin Chim Acta       Date:  2015-06-18       Impact factor: 3.786

6.  Red blood cell distribution width and the risk of death in middle-aged and older adults.

Authors:  Kushang V Patel; Luigi Ferrucci; William B Ershler; Dan L Longo; Jack M Guralnik
Journal:  Arch Intern Med       Date:  2009-03-09

7.  Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients.

Authors:  Domingo A Pascual-Figal; Juan C Bonaque; Belen Redondo; Cesar Caro; Sergio Manzano-Fernandez; Jesús Sánchez-Mas; Iris P Garrido; Mariano Valdes
Journal:  Eur J Heart Fail       Date:  2009-09       Impact factor: 15.534

8.  Endogenous erythropoietin and outcome in heart failure.

Authors:  Anne M S Belonje; Adriaan A Voors; Peter van der Meer; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

9.  Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.

Authors:  G Michael Felker; Larry A Allen; Stuart J Pocock; Linda K Shaw; John J V McMurray; Marc A Pfeffer; Karl Swedberg; Duolao Wang; Salim Yusuf; Eric L Michelson; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2007-06-18       Impact factor: 24.094

10.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983
View more
  1 in total

1.  The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial.

Authors:  Gholamreza Askari; Amirhossein Sahebkar; Davood Soleimani; Atena Mahdavi; Sahar Rafiee; Muhammed Majeed; Farzin Khorvash; Bijan Iraj; Mahshid Elyasi; Mohammad Hossein Rouhani; Mohammad Bagherniya
Journal:  Trials       Date:  2022-06-06       Impact factor: 2.728
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.